PHRMACOKOKINETIC AND PHRMACODYNAMIC DRUG EFFECT ON INFANT AND YOUNG PEOPLE.

Drug concentration and its impact on the body are largely determined by pharmacokinetics (PK) and pharmacodynamics (PD). Pharmacokinetics explains how a drug is absorbed, distributed, metabolized, and eliminated by the body, regulating concentration over time. The link between drug concentration at the site of action and the ensuing beneficial or detrimental effect is explained by pharmacodynamics. The strength and duration of a medicine's action can be affected by changes in drug concentration. It is easier to choose the right dose, dosing interval, and treatment plan when one is aware of the connection between PK and PD. New born, children and young adults may have very different Drug concentrations and effect due to age related changes in pharmacokinetics. Drug concentrations in the body can change due to developmental variations in absorption, distribution, metabolism, and excretion (ADME). Drug exposure and excretion can be impacted by changes in body water and fat, plasma protein binding, liver enzyme activity, and renal function. In order to determine and assess dosage-concentration-response relationships and to forecast. It can aid in drug development and be helpful in comprehending the connection between drug concentration and pharmacological response.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-30
DOI
https://doi.org/10.5281/zenodo.23793026
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PHRMACOKOKINETIC AND PHRMACODYNAMIC DRUG EFFECT ON INFANT AND YOUNG PEOPLE.

Kiran Bhausaheb Dhamak, Sakshi Thorat, Nikita Phad, Gaytri Kadave et al.
Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical studies and practices
article

PHRMACOKOKINETIC AND PHRMACODYNAMIC DRUG EFFECT ON INFANT AND YOUNG PEOPLE.

Kiran Bhausaheb Dhamak, Sakshi Thorat, Nikita Phad, Gaytri Kadave, Vikshita Patil
article en

Abstract

Drug concentration and its impact on the body are largely determined by pharmacokinetics (PK) and pharmacodynamics (PD). Pharmacokinetics explains how a drug is absorbed, distributed, metabolized, and eliminated by the body, regulating concentration over time. The link between drug concentration at the site of action and the ensuing beneficial or detrimental effect is explained by pharmacodynamics. The strength and duration of a medicine's action can be affected by changes in drug concentration. It is easier to choose the right dose, dosing interval, and treatment plan when one is aware of the connection between PK and PD. New born, children and young adults may have very different Drug concentrations and effect due to age related changes in pharmacokinetics. Drug concentrations in the body can change due to developmental variations in absorption, distribution, metabolism, and excretion (ADME). Drug exposure and excretion can be impacted by changes in body water and fat, plasma protein binding, liver enzyme activity, and renal function. In order to determine and assess dosage-concentration-response relationships and to forecast. It can aid in drug development and be helpful in comprehending the connection between drug concentration and pharmacological response.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 7%
Pharmaceutical studies and practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
PHRMACOKOKINETIC AND PHRMACODYNAMIC DRUG EFFECT ON INFANT AND YOUNG PEOPLE. — Kiran Bhausaheb Dhamak, Sakshi Thorat, et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS